Robbins Geller Obtains Preliminary Approval of $400 million Securities Class Action Settlement Against Pfizer Inc.
On March 16, 2015, the Court entered an order granting preliminary approval to the $400 million settlement obtained by Robbins Geller on the eve of trial against Pfizer.
The final approval hearing is currently scheduled for July 30, 2015 at 2:30 p.m. at the U.S. District Court for the Southern District of New York, 500 Pearl Street, Courtroom 14D, New York, New York 10007. Additional information about the settlement, case documents, and deadlines associated with the settlement can be found at http://www.pfizersecuritiessettlement.com/
Read More Firm News
- “Landmark” $650 Million Settlement in Facebook Biometric Class Action Approved as a “Major Win” for Consumers in the Area of Digital PrivacyFebruary 26, 2021
- February 17, 2021
- Robbins Geller’s Desiree Cummings Appointed to Plaintiffs’ Steering Committee in Blackbaud Data Breach MDLFebruary 17, 2021
- February 8, 2021
- Litigators of the Week: How Robbins Geller Landed a $1.2B Settlement in the Valeant Pharmaceuticals Securities CaseFebruary 5, 2021